clinical trials

See the following -

NY Attorney General Confirms Real-Life Conspiracy Among Drug Companies

J.D. Heyes | Natural News | February 21, 2014

The office of the New York Attorney General and the American units of Ranbaxy Laboratories Ltd. and Teva Pharmaceutical Industries Ltd. have come to terms on a settlement involving claims that an agreement between the two Big Pharma companies restricted competition unlawfully. Read More »

Open Access in Europe to Big Pharma clinical trial data

Andrew Jack | Financial Times | April 4, 2013

When Guido Rasi took charge of Europe’s medicines’ regulator in 2011 he inherited an explosive dossier that is now poised to transform drug development. Read More »

Open Source Software being used in Clinical Research

Andy Oram | O'Reilly Strata | June 25, 2013

Report from OpenClinica Conference: There are about 1200 OpenClinica installations around the world, although estimation is always hard to do with open source projects. Read More »

Open Source Software Creeps into Healthcare through Clinical Research

Although open source has not conquered the lucrative market for electronic health records (EHRs) used by hospital systems and increasingly by doctors, it is making strides in many other important areas of health care. One example is clinical research, as evidenced by OpenClinica in field of Electronic Data Capture (EDC) and LabKey for data integration. Last week I attended a conference for people who use OpenClinica in their research or want to make their software work with it. At any one time, hundreds of thousands of clinical trials are going on around the world, many listed on an FDA site. Many are low-budget and would be reduced to using Excel spreadsheets to store data if they didn’t have the Community edition of OpenClinica. Read More »

Open-source Code Leads to the Adoption of University of Minnesota's StudyFinder by Additional Translational Medicine Research Institutions

Press Release | University Of Minnesota Academic Health Center | April 26, 2016

The University of Minnesota is expanding access to clinical trials and supporting the health research community by sharing its clinical trial resource, StudyFinder, with other institutions designated with Clinical and Translational Science Awards (CTSA), a program spearheaded by the National Institutes of Health (NIH). StudyFinder is an online tool pooling clinical trials and research studies in one space, with easy-to-understand language and functions. It helps patients and healthy volunteers get involved and allows researchers to publicize their clinical trials and connect with study volunteers.

OpenClinica Enterprise Works For Boutique CROs Like Cancer InCITe

Press Release | OpenClinica | July 2, 2013

OpenClinica, LLC announces that Cancer InCITe, LLC of San Antonio, Texas has selected the OpenClinica Enterprise Edition for Electronic Data Capture (EDC) and clinical data management for phase 1 and phase 2 clinical trials. [...] Read More »

OpenClinica Releases Enhancements To Clinical Trial Software

Press Release | OpenClinica, LLC | December 3, 2012

OpenClinica, LLC, announces the availability of the latest version of its popular open source clinical trials software. The OpenClinica v3.1.3 release contains over 100 fixes and enhancements, including [the following]: Read More »

OpenClinica selected for use in Clinical Trials by Cancer InCITe

Press Release | OpenClinica | July 2, 2013

OpenClinica, LLC announces that Cancer InCITe, LLC of San Antonio, Texas has selected the OpenClinica Enterprise Edition for Electronic Data Capture (EDC) and clinical data management for phase 1 and phase 2 clinical trials. Read More »

Opening Up the FDA

The President's Executive Order on Open Government Data states, "Government information shall be managed as an asset throughout its life cycle to promote interoperability and openness, and, wherever possible and legally permissible, to ensure that data are released to the public in ways that make the data easy to find, accessible, and usable." Interestingly, the Department of Health and Human Services (HHS), which includes the Food & Drug Administration (FDA), has a tradition of expansive disclosure of information and/or data it generates or collects – contrary to current practices at the FDA. Hopefully, changes being made to 'open up' the FDA will start to accelerate. Read More »

Patients Matter Most, But Technology Matters A Lot

Andy Oram | O'Reilly Strata | June 1, 2013

Computing practices that used to be religated to experimental outposts are now taking up residence at the center of the health care field. From natural language processing to machine learning to predictive modeling, you see people promising at the health data forum (Health Datapalooza IV) to do it in production environments. Read More »

Pharma Not So Big On Cloud For Clinical Trials

Chris Anderson | Government Health IT | December 26, 2012

Big pharma is notoriously slow-footed when it comes to changing its business model. Some would argue it is a major reason why so many pharmaceutical companies are struggling as their blockbuster drugs go off patent. In short, there is an institutionalized caution to embracing the kind of change moving to the cloud presents.

Read More »

Phase II Trials Of TB Drug Through Open Source Drug Discovery Programme To Begin Soon

Joseph Alexander | Pharmabiz.com | July 22, 2013

The search for a new tuberculosis drug after many decades and first time through a unique model of open drug discovery programme may finally bear fruits in near future, with India all set for the launch of the phase II clinical trial of the drug candidate. Read More »

PraediTrial

Identifying clinical trial sites that can fulfill subject recruitment goals can be a costly, time consuming, and inaccurate process.  PraediTrial is a tool developed by Bitscopic that ensures a realistic assessment of trial sites’ subject population and capabilities to successfully conduct a clinical trial. In addition, PraediTrial stays with you through the recruitment cycle providing study coordinators with alerts to easily identify subjects for your trial.

Read More »

RandomiseMe: Our Fun New Website That Lets Anyone Design And Run A Randomised Controlled Trial.

Ben Goldacre | Bad Science | December 16, 2013

Catching up and blogging this year’s activities: here’s a fun website I made with my friend Carl Reynolds, fellow doctor behind NHS HackDays (where nerds who love the NHS build useful tools). RandomiseMe lets you design and run randomised controlled trials, either on yourself, or on your friends. [...] Read More »

Re-thinking Clinical Trials For The World Of Crowdsourcing

Laurie Halloran | Xconomy | April 16, 2013

Disruption isn’t a word normally associated with clinical drug development, but nevertheless it is coming. [...] There are signals that drug development is starting to catch up with the general trend toward open collaboration and innovation. This trend is enabling tremendous advances in other industries, so why not ours? Read More »